Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 47

Adult ID

Global ID

Investigative ID

Trainee
Symposium

133 - Clinical Trials That May Change Your Practice

Saturday, October 2, 2021
1:15 PM - 3:00 PM EDT

    Moderator(s)

  • Jessica Howard-Anderson, MD, MSc

    Assistant Professor
    Emory University School of Medicine
    Atlanta, GA, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Thomas Holland, MD

    Associate Professor, Department of Medicine, Division of Infectious Diseases
    Duke University
    Raleigh, NC, United States

    Aridis (Individual(s) Involved: Self): Consultant; Basilea Pharmaceutica (Individual(s) Involved: Self): blinded adjudication, Consultant, Other Financial or Material Support; Genentech (Individual(s) Involved: Self): Consultant; Lysovant (Individual(s) Involved: Self): Consultant; Motif Bio (Individual(s) Involved: Self): Consultant

    • Speaker(s)

  • DY

    Dafna Yahav

    Tel Aviv University, Rabin Medical Center

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Thuy Le, MD, PhD

    Associate Professor of Medicine, Molecular Genetics and Microbiology
    Duke University School of Medicine
    Durham, NC, United States

    Gilead Sciences (Individual(s) Involved: Self): Grant/Research Support

  • Genovefa Papanicolaou, MD

    Attending
    Infectious Diseases Service, Department of Medicine
    Memorial Sloan Kettering
    New York, New York, United States

    allovir (Individual(s) Involved: Self): Consultant; amplyx (Individual(s) Involved: Self): Consultant; behring (Individual(s) Involved: Self): Consultant; Merck&Co (Individual(s) Involved: Self): Consultant, Investigator and received funding and consulting fees from Merck, Chimerix, Shire and Astellas, Research Grant or Support; octapharma (Individual(s) Involved: Self): Consultant; Partners Therapeutics (Individual(s) Involved: Self): Consultant; takeda (Individual(s) Involved: Self): Consultant, Scientific Research Study Investigator

Participants should be aware of the following financial/non-financial relationships:
Jessica Howard-Anderson, MD, MSc: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Thomas L. Holland, MD: Aridis (Individual(s) Involved: Self): Consultant; Basilea Pharmaceutica (Individual(s) Involved: Self): blinded adjudication, Consultant, Other Financial or Material Support; Genentech (Individual(s) Involved: Self): Consultant; Lysovant (Individual(s) Involved: Self): Consultant; Motif Bio (Individual(s) Involved: Self): Consultant
Dafna Yahav: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Thuy Le, MD, PhD: Gilead Sciences (Individual(s) Involved: Self): Grant/Research Support
Genovefa Papanicolaou, MD: allovir (Individual(s) Involved: Self): Consultant; amplyx (Individual(s) Involved: Self): Consultant; behring (Individual(s) Involved: Self): Consultant; Merck&Co (Individual(s) Involved: Self): Consultant, Investigator and received funding and consulting fees from Merck, Chimerix, Shire and Astellas, Research Grant or Support; octapharma (Individual(s) Involved: Self): Consultant; Partners Therapeutics (Individual(s) Involved: Self): Consultant; takeda (Individual(s) Involved: Self): Consultant, Scientific Research Study Investigator

CME Credits: Maximum of 1.75 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.75 hours of MOC Credit
ACPE Credits: ACPE 1.75 Knowledge-based contact hours of pharmacy CE
ACPE Number:

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • assess the most impactful recent clinical trials in viral, fungal, and bacterial diseases
  • evaluate new trial data critically
  • discuss the implications of new data for their clinical practice

Presentations:

  • Clinical Trials in Bacterial Diseases That May Change Your Practice

    Speaker: Dafna Yahav – Tel Aviv University, Rabin Medical Center

  • Clinical Trials in Fungal Diseases That May Change Your Practice

    Speaker: Thuy Le, MD, PhD – Duke University School of Medicine

  • Clinical Trials in Viral Diseases That May Change Your Practice

    Speaker: Genovefa Papanicolaou, MD – Memorial Sloan Kettering